[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354291-105":59,"doc-detail-354291-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","predicting-5-year-mortality-in-non-small-cell-lung-cancer-using-the-korean-central-cancer-registry-model-development-and-validation-study","Predicting 5-Year Mortality in Non-Small-Cell Lung Cancer Using the Korean Central Cancer Registry - Model Development and Validation Study","","Non–small-cell lung cancer remains a major cause of cancer-related mortality, and accurate prognostic prediction is essential for clinical planning. This study developed deep learning models to predict 5-year mortality using Korea Central Cancer Registry data and applied permutation testing to quantify feature importance. A cohort of 3,144 patients (2014-2017) with complete clinical, pulmonary, histological, genomic, and staging data was partitioned 70/15/15 for stratified training, validation, and testing.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/predicting-5-year-mortality-in-non-small-cell-lung-cancer-using-the-korean-central-cancer-registry-model-development-and-validation-study/354291/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/predicting-5-year-mortality-in-non-small-cell-lung-cancer-using-the-korean-central-cancer-registry-model-development-and-validation-study/354291.png","ImageObject",300,407,{"name":92,"@type":93},"Grenda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study objective for NSCLC mortality prediction?","Question",{"text":112,"@type":113},"To develop deep learning models predicting 5-year mortality in NSCLC using Korea Central Cancer Registry data and to quantify feature importance via permutation testing.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the dataset constructed and split for model development?",{"text":117,"@type":113},"The study used 3,144 patients diagnosed between 2014 and 2017 with complete clinical, pulmonary function, histological, genomic, and staging information, split into stratified training, validation, and test sets in a 70%-15%-15% ratio.",{"name":119,"@type":110,"acceptedAnswer":120},"Which evaluation metric and feature-importance method were used?",{"text":121,"@type":113},"Model discrimination was evaluated primarily using AUC, with additional metrics including accuracy, F1-score, precision, and recall. Groupwise permutation importance was computed for each model, and agreement of importance rankings was assessed with the Friedman test.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354291,1790930055,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","JMIR MEDICAL INFORMATICS Lee et al  \nOriginal Paper  \nPredicting 5-Year Mortality in Non–Small-Cell Lung Cancer Using the Korean Central Cancer Registry: Model Development and Validation Study  \n\n| Jong Hyuk Lee 1 , MD; Ho Cheol Kim2 , MD, PhD; Kyu-Won Jung3 , MS; Chang Min Choi 1,2 , MD, PhD |\n| --- |\n| 1Department of Oncology, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea\u003Cbr>2Department of Pulmonary and Critical Care Medicine, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea 3Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea\u003Cbr>Corresponding Author:\u003Cbr>Chang Min Choi, MD, PhD\u003Cbr>Department of Pulmonary and Critical Care Medicine College of Medicine, Asan Medical Center, University of Ulsan\u003Cbr>88, Olympic-ro 43-gil, Songpa-gu\u003Cbr>Seoul 05505\u003Cbr>Republic of Korea Phone: +82-10-9792-9607\u003Cbr>Email: [ccm@amc.seoul.kr](ccm@amc.seoul.kr)\u003Cbr>Abstract |\n| Background: Non–small-cell lung cancer (NSCLC) is one of the most common cancers and a leading cause of cancer-related mortality, making prognostic prediction clinically essential. Machine learning models are increasingly used to assess prognosis; however, developing systems that combine high discrimination with clear, clinically interpretable reasoning remains challenging.\u003Cbr>Objective: This study aimed to develop deep learning models that predict 5-year mortality in NSCLC using data from the Korea Central Cancer Registry and quantify feature importance through permutation testing.\u003Cbr>Methods: We identified 3144 patients diagnosed between 2014 and 2017 who had complete clinical data, pulmonary function test results, histological information, genomic data, and staging details. After preprocessing, the cohort was divided into stratified training, validation, and test sets in a 70%-15%-15% ratio. Five models were tuned using Hyperband across 10 predefined feature groups. The primary evaluation metric was the area under the receiver operating characteristic curve (AUC); additional metrics included accuracy, F1-score, precision, and recall. Groupwise permutation importance was calculated for each model, and the concordance of importance rankings was assessed using the Friedman test.\u003Cbr>Results: All 5 models yielded comparable discrimination values on the test set (AUC=0.875‐0.879) . Model A was selected as the primary model and achieved an AUC of 0.879, an accuracy of 0.806, an F1-score of 0.824, and a Brier score of 0.142. Permuting the stage resulted in the largest decrease in AUC (0.217), followed by the pulmonary function test (0.016) . Gene mutation had a modest overall impact but became more influential within the adenocarcinoma subset. The Friedman test showed no statistically significant differences in importance rankings across the models (P= .93) .\u003Cbr>Conclusions: A grouped-input deep learning framework achieved discrimination comparable to a conventional Cox proportional hazards model using the same routine clinical variables for 5-year mortality prediction in NSCLC. Group-level permutation importance provided stable and reproducible insights into the clinical factors influencing risk, which may guide future model refinement and clinical decision-making.\u003Cbr>JMIR Med Inform 2026;14:e80574; doi:  10.2196/80574 |\n\nKeywords: non–small-cell lung cancer; deep learning; machine learning; prognosis; Korean Central Cancer Registry; KCCR; permutation tests  \n[https://medinform.jmir.org/2026/1/e80574](https://medinform.jmir.org/2026/1/e80574) JMIR Med Inform 2026 | vol. 14 | e80574 | p. 1  \n(page number not for citation purposes)  \nJMIR MEDICAL INFORMATICS Lee et al  \nIntroduction  \nNon–small-cell lung cancer (NSCLC) is one of the most prevalent cancers worldwide and, despite advancements in prognosis, remains a leading cause of cancer-related mortality [1-3] . The prognosis of NSCLC is influenced by various factors, includi","cbCaipoSj2QlZOhh","https://ap.wps.com/l/cbCaipoSj2QlZOhh","pdf",461426,14,"English","# Abstract\n## Background\n## Objective\n## Methods\n## Results\n## Conclusions\n# Keywords\n# Introduction","[{\"question\":\"What was the study objective for NSCLC mortality prediction?\",\"answer\":\"To develop deep learning models predicting 5-year mortality in NSCLC using Korea Central Cancer Registry data and to quantify feature importance via permutation testing.\"},{\"question\":\"How was the dataset constructed and split for model development?\",\"answer\":\"The study used 3,144 patients diagnosed between 2014 and 2017 with complete clinical, pulmonary function, histological, genomic, and staging information, split into stratified training, validation, and test sets in a 70%-15%-15% ratio.\"},{\"question\":\"Which evaluation metric and feature-importance method were used?\",\"answer\":\"Model discrimination was evaluated primarily using AUC, with additional metrics including accuracy, F1-score, precision, and recall. Groupwise permutation importance was computed for each model, and agreement of importance rankings was assessed with the Friedman test.\"}]","Predicting 5-Year Mortality in Non-Small-Cell Lung Cancer Using the Korean Central Cancer Registry - Model Development and Validation Study | PDF",1790109896,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/782b24bb114e44d057e241cb8e764367.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/62bb5d4163e7a14254f391c3fde56170.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/beb98d98a9b2342a70dc3e7b9e84a3e2.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b83e70de751bd7c27ffdaa2211a50f7.webp",980,1385]